{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:38:07Z","timestamp":1776260287106,"version":"3.50.1"},"reference-count":61,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5551\/jat.15180","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T23:21:28Z","timestamp":1350084088000},"page":"215-227","source":"Crossref","is-referenced-by-count":25,"title":["MicroRNAs: Important Modulators of oxLDL-Mediated Signaling in Atherosclerosis"],"prefix":"10.5551","volume":"20","author":[{"given":"Erli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 2006; 367: 1747-1757","DOI":"10.1016\/S0140-6736(06)68770-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lusis AJ: Atherosclerosis. Nature, 2000; 407: 233-241","DOI":"10.1038\/35025203"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.5551\/jat.3939"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Jialal I, Devaraj S: The role of oxidized low density lipoprotein in atherogenesis. J Nutr, 1996; 126: 1053S-1057S","DOI":"10.1093\/jn\/126.suppl_4.1053S"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2733"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation, 2004; 109: III27-32","DOI":"10.1161\/01.CIR.0000131515.03336.f8"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.5551\/jat.3228"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kowala MC: The role of endothelin in the pathogenesis of atherosclerosis. Adv Pharmacol, 1997; 37: 299-318","DOI":"10.1016\/S1054-3589(08)60953-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Rubanyi GM, Polokoff MA: Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev, 1994; 46: 325-415","DOI":"10.1016\/S0031-6997(25)06809-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Li D, Yang P, Xiong Q, Song X, Yang X, Liu L, Yuan W, Rui YC: MicroRNA-125a\/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J Hypertens, 2010; 28: 1646-1654","DOI":"10.1097\/HJH.0b013e32833a4922"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mitra S, Khaidakov M, Lu J, Ayyadevara S, Szwedo J, Wang XW, Chen C, Khaidakov S, Kasula SR, Stone A, Pogribny I, Mehta JL: Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol, 2011; 301: H506-513","DOI":"10.1152\/ajpheart.00252.2011"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.05.118"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Li D, Yang B, Mehta JL: Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol, 1998; 275: H568-576","DOI":"10.1152\/ajpheart.1998.275.2.H568"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1096\/fj.99-0986com"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.04.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, Wang C: MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte\/macrophages. Cardiovasc Res, 2009; 83: 131-139","DOI":"10.1093\/cvr\/cvp121"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Olkkonen VM: Oxysterol binding protein and its homologues: new regulatory factors involved in lipid metabolism. Curr Opin Lipidol, 2004; 15: 321-327","DOI":"10.1097\/00041433-200406000-00013"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E06-01-0060"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.02.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Maa MC, Chang MY, Li J, Li YY, Hsieh MY, Yang CJ, Chen YJ, Li Y, Chen HC, Cheng WE, Hsieh CY, Cheng CW, Leu TH: The iNOS\/Src\/FAK axis is critical in Tolllike receptor-mediated cell motility in macrophages. Biochim Biophys Acta, 2011; 1813: 136-147","DOI":"10.1016\/j.bbamcr.2010.09.004"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.045104"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.4.669"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200323375"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.008"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605298103"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1038\/nri1391"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) de Winther MP, Kanters E, Kraal G, Hofker MH: Nuclear factor kappaB signaling in atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2005; 25: 904-914","DOI":"10.1161\/01.ATV.0000160340.72641.87"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC: MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. Journal of investigative medicine: the official publication of the American Federation for Clinical Research, 2010; 58: 961-967","DOI":"10.2310\/JIM.0b013e3181ff46d7"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.10.133"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW: Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nature Medicine, 2004; 10: 416-421","DOI":"10.1038\/nm1008"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.02.063"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Leon B, Lopez-Bravo M, Ardavin C: Monocyte-derived dendritic cells. Seminars in Immunology, 2005; 17: 313","DOI":"10.1016\/j.smim.2005.05.013"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.01.010"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.05.006"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E: CD40\/CD40L signaling and its implication in health and disease. Biofactors, 2009; 35: 474-483","DOI":"10.1002\/biof.62"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1002\/art.27443"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC: NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell, 2008; 14: 369-381","DOI":"10.1016\/j.ccr.2008.10.006"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 2008; 105: 13027-13032","DOI":"10.1073\/pnas.0805038105"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.01.027"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600304-JLR200"},{"key":"42","unstructured":"42) Rudijanto A: The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta medica Indonesiana, 2007; 39: 86-93"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-174904"},{"key":"44"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20050845"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.092767"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1038\/nature10572"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R: Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proceedings of the National Academy of Sciences of the United States of America, 2008; 105: 9047-9052","DOI":"10.1073\/pnas.0803623105"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Kang S, Wu Y, Li X: Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis, 2004; 177: 433-442","DOI":"10.1016\/j.atherosclerosis.2004.08.005"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0208"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Tousoulis D: Editorial inflammation in atherosclerosis: current therapeutic approaches. Current Pharmaceutical Design, 2011; 17: 4087-4088","DOI":"10.2174\/138161211798764762"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.7.898"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet, 2004; 364: 937-952","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Drakopoulou M, Toutouzas K, Michelongona A, Tousoulis D, Stefanadis C: Vulnerable plaque and inflammation: potential clinical strategies. Current Pharmaceutical Design, 2011; 17: 4190-4209","DOI":"10.2174\/138161211798764816"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.226456"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Reid G, Kirschner MB, van Zandwijk N: Circulating microRNAs: Association with disease and potential use as biomarkers. Critical Reviews in Oncology\/Hematology, 2011; 80: 193-208","DOI":"10.1016\/j.critrevonc.2010.11.004"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2210"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Heightman TD: Therapeutic prospects for epigenetic modulation. Expert Opinion on Therapeutic Targets, 2011; 15: 729-740","DOI":"10.1517\/14728222.2011.561786"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Kim SI, Shin D, Choi TH, Lee JC, Cheon GJ, Kim KY, Park M, Kim M: Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. Molecular therapy : the journal of the American Society of Gene Therapy, 2007; 15: 1145-1152","DOI":"10.1038\/sj.mt.6300168"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Brueckner B, Garcia Boy R, Siedlecki P, Musch T, Kliem HC, Zielenkiewicz P, Suhai S, Wiessler M, Lyko F: Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Research, 2005; 65: 6305-6311","DOI":"10.1158\/0008-5472.CAN-04-2957"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Pogribny IP, Beland FA: DNA hypomethylation in the origin and pathogenesis of human diseases. Cellular and Molecular Life Sciences : CMLS, 2009; 66: 2249-2261","DOI":"10.1007\/s00018-009-0015-5"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T18:05:23Z","timestamp":1744394723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/20\/3\/20_15180\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.15180","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}